eeg
(6)
Nadia Kumentas Is Teaching Brain Technology to Speak Human
The Muse CMO built her career at the border between science and storytelling. Her operating lesson is simple: when a product creates a new category, education is not support for the marketing - it is the marketing.
Ramses Alcaide
Dr. Ramses Alcaide is the co-founder and CEO of Neurable, a Boston-based neurotechnology company building brain-computer interfaces disguised as ordinary headphones. A neuroscientist trained at the University of Washington and the University of Michigan, he turned a decade of EEG research into the MW75 Neuro, a Master & Dynamic collaboration that reads brainwaves to help wearers focus. Neurable has raised roughly $49M, closed a Series A in late 2025, and unveiled a HyperX gaming headset at CES 2026.
Meredith Perry
Meredith Perry is the co-founder and CEO of Elemind, a neurotech company building a wearable headband that reads your brainwaves in real time and nudges them with bursts of sound, marketed as sleep on demand. Before Elemind she was the inventor behind uBeam, the ultrasonic wireless-charging venture she dreamed up as a University of Pennsylvania undergrad and grew into a roughly $40 million, much-debated startup backed by Founders Fund, Andreessen Horowitz, Mark Cuban and Marissa Mayer. A trained paleobiologist and astrobiologist who once did research with NASA, Perry holds dozens of patents and now wants to build what she calls an app store for the brain.
Dan Furman
Dan Furman is a neuroscientist and the co-founder and CEO of Arctop, a company building the software intelligence layer that decodes human brain signals in real time from everyday wearables like headbands, earbuds and VR headsets. A Harvard-trained neurobiologist with a Technion PhD, he once helped adapt a sleep-monitoring device into a brain-computer interface for Stephen Hawking, and his doctoral work showed that non-invasive scalp sensors could control individual neuroprosthetic fingers. In 2023 Arctop raised a $10M Series A to apply its 'Brain ID' and real-time cognition technology across medicine, education, cybersecurity and entertainment.
David Matthews
David Matthews, PhD, is Chief Business Officer at Beacon Biosignals, the computational neurodiagnostics company turning EEG brain data into AI-powered biomarkers for neurological and psychiatric disease. A computational neuroscientist by training, he spent two decades moving between the lab, the boardroom, and the market - from NIH- and NSF-funded research at the Salk Institute to a partnership at Boston Consulting Group to commercial leadership at digital-health platform BrightInsight. He now drives partnerships and commercial growth at a company betting that the brain can be measured at home, at scale.
Jacob Donoghue
Jacob Donoghue is a physician-scientist and the co-founder and CEO of Beacon Biosignals, a Boston company applying machine learning to EEG brain data to build neurobiomarkers for psychiatric, neurological, and sleep disorders. Trained with an MD from Harvard Medical School and a PhD in neuroscience from MIT, he started Beacon in 2019 on the bet that decades of overlooked brainwave recordings could be turned into a precision-medicine engine for drug development and diagnosis. Under his leadership the company has raised over $116M, secured FDA clearance for a wearable EEG headband, acquired home sleep-testing firm CleveMed, and partnered with more than half of the world's top ten biopharma companies.